IMPAX LABORATORIES INC
10QSB, EX-27, 2000-10-31
PHARMACEUTICAL PREPARATIONS
Previous: IMPAX LABORATORIES INC, 10QSB, 2000-10-31
Next: NATIONSCREDIT GRANTOR TRUST 1996-1, 8-K, 2000-10-31



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET (UNAUDITED) AND THE CONSOLIDATED STATEMENT OF INCOME
FOR THE SIX MONTHS ENDED SEPTEMBER, 2000 (UNAUDITED) AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           5,333
<SECURITIES>                                     2,815
<RECEIVABLES>                                    3,070
<ALLOWANCES>                                        75
<INVENTORY>                                      3,670
<CURRENT-ASSETS>                                15,685
<PP&E>                                          10,275
<DEPRECIATION>                                     969
<TOTAL-ASSETS>                                  59,192
<CURRENT-LIABILITIES>                            8,653
<BONDS>                                              0
                           36,730
                                          0
<COMMON>                                           252
<OTHER-SE>                                      11,675
<TOTAL-LIABILITY-AND-EQUITY>                    59,192
<SALES>                                          8,203
<TOTAL-REVENUES>                                 8,203
<CGS>                                            7,480
<TOTAL-COSTS>                                    7,480
<OTHER-EXPENSES>                                20,401
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (19,157)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (19,157)
<EPS-BASIC>                                     (0.77)
<EPS-DILUTED>                                   (0.77)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission